Attention Deficit Hyperactivity Disorder
Shire to Present Important Study Findings on its ADHD Treatments at a Major Psychiatric Meeting on October 29 and 30
Published in Drug Law Weekly, November 10th, 2009
Shire plc , the global specialty biopharmaceutical company, announced that it will present key scientific data on its Attention-Deficit/Hyperactivity Disorder (ADHD) treatments, INTUNIV™ (guanfacine) Extended Release Tablets, Vyvanse=AE (lisdexamfetamine dimesylate) Capsules CII, and Daytrana=AE (methylphenidate transdermal system) CII, at a national meeting of psychiatrists to be held October 27 - November 1 in Honolulu.
"Shire is committed to the advancement of ADHD treatment research and is leading the way in developing a diverse range of safe and effective ADHD treatments," said Michael Yasick, Senior Vice President of the Shire ADHD Business Unit. "We are...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
Source: Drug Law Weekly (2009-11-10)
More Articles from Drug Law Weekly
- Allergan, Inc.
Allergan Announces Victory in Brimonidine Patent Infringement Case - Audible Inc.
Jeffery Deaver, Lisa Scottoline and Lee Child Contribute to New Thriller Exclusively for Audio - BIO-key International, Inc.
BIO-key(R) International Exhibiting at AABB TXPO - Biopharmaceuticals
PDL BioPharma Announces Pricing of $300,000,000 Securitization Transaction - Biotech Business
Stryker Statement in Response to the Indictment of Its Biotech Division - Bone Research
Stryker Biotech and its Top Management Indicted for Illegal Promotion of Medical Devices Used in Invasive Surgeries - More from this issue of Drug Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
